GlassScriptPhysician profile
Eduardo Violago
NPI 1679540140
$2,809.49
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $571 · 2021: $766 · 2022: $345 · 2023: $31.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $468.98 | 2019-2023 | Relistor |
| Biodelivery Sciences International, INC. | $452.93 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $304.98 | 2019-2022 | |
| Pfizer INC. | $212.63 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $188.64 | 2019-2023 | Ztlido |
| Redhill Biopharma INC. | $150.98 | 2020-2021 | |
| Amgen INC. | $141.52 | 2019-2021 | |
| Daiichi Sankyo INC. | $119.52 | 2019 | |
| Medtronic USA, INC. | $109.09 | 2019-2020 | |
| Boston Scientific Corporation | $108.47 | 2019-2021 | |
| Forte Bio-Pharma LLC | $106.55 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $76.70 | 2021 | |
| Assertio Therapeutics, INC. | $68.51 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $52.72 | 2019-2021 | |
| Ibsa Pharma INC. | $39.10 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36.63 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.58 | 2022 | |
| Mdd US Operations, LLC | $29.70 | 2019 | |
| Allergan, INC. | $27.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.43 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $16.79 | 2019 | |
| Grt US Holding, INC. | $13.95 | 2021 | |
| Shionogi INC | $13.78 | 2019 | |
| Protega Pharmaceutials INC | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Violago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.